Widespread use of alternative payment models may improve the quality of breast and colorectal cancer screening programs. READ MORE
Overall costs of radiation therapy for early-stage breast cancer do not burden the health care system when analyzed in relation to survival benefit.
Weight loss was associated with a reduced risk for breast cancer among postmenopausal women.
Nearly one in five women with early-stage breast cancer received guideline-discordant treatment, usually with regards to chemotherapy use.
A 21-gene assay poses an overall incremental cost increase to the health care system in the short-term, despite lower rates of chemotherapy use.